Prevalence of inducible clindamycin resistance in staphylococcal isolates at a Korean Tertiary Care Hospital

Yonsei Medical Journal

Volumn 47, Issue 4, 2006, Pages 480-484

  Lim, Hwan Sub ^a   Lee, Hyukmin ^a   Roh, Kyoung Ho ^b   Yum, Jong Hwa ^b   Yong, Dongeun ^b   Lee, Kyungwon ^b   Chong, Yunsop ^b  

^a Kwandong University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Antibiotic resistance; Clindamycin; Staphylococcus

Indexed keywords

CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; METICILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; KOREA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PREVALENCE; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 33748305675     PISSN: 05135796     EISSN: 05135796     Source Type: Journal    
DOI: 10.3349/ymj.2006.47.4.480     Document Type: Article

References (16)

1. Lee K, Park KH, Jeong SH, Lim HS, Shin JH, Yong D, et al. Further increase of vancomycin-resistant Enterococcus faecium, amikacin- and fluoroquinolone-resistant Klebsiella pneumoniae, and imipenem-resistant Acinetobacter spp. In Korea: 2003 KONSAR surveillance. Yonsei Med J 2006;47:43-54.
2. Frank AL, Marcinak JF, Mangat PD, Tjhio JT, Kelkar S, Schreckenberger PC, et al. Clindamycin treatment of methicillin-resistant Staphylococcus aurcus infections in children. Pediatr Infect Dis J 2002;21:530-4.
3. Martinez-Aguilar G, Hammerman WA, Mason EO Jr, Kaplan SL. Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aurcus in children. Pediatr Infect Dis J 2003;22:593-8
4. Ladhani S, Garbash M. Staphylococcal skin infections in children: rational drug therapy recommendations. Paediatr Drugs 2005;7:77-102.
5. Leclereq R, Courvalin P. Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrob Agents Chemother 1991;35:1267-72.
6. Weisblum B. Resistance to the macrolide-lincosamide-streptogramin antibiotics. In: Fischetti VA, Novick, RP, Ferretti JJ, Portnoy DA, Rood JI, editors. In gram-positive pathogens. Washington DC: ASM Press; 2000. p.694
7. Drinkovic D, Fuller ER, Shore KP, Holland DJ, Ellis-Pegler R. Clindamycin treatment of Staphylococcus aureus expressing inducible clindamycin resistance. J Antimicrob Chemother 2001;48:315-6.
8. Jorgensen JH, Crawford SA, McElmeel ML, Fiebelkorn KR. Detection of inducible clindamycin resistance of staphylococci in conjunction with performance of automated broth susceptibility testing. J Clin Microbiol 2004;42:1800-2.
9. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; fifteenth informational supplement M100-S14, Wayne, PA, CLSI, 2005.
10. Fiebelkorn KR, Crawford SA, McElmeel ML, Jorgensen JH. Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J Clin Microbiol. 2003;41:4740-4.
11. Sanchez ML, Flint KK, Jones RN. Occurrence of microlide-lincosamide-streptogramin resistances among staphylococcal clinical isolates at a university medical center. Is false susceptibility to new macrolides and clindamycin a contemporary clinical and in citro testing problem? Diagn Microbiol Infect Dis 1993;16:205-13.
12. Lampson BC, Parisi JT. Naturally occurring Staphylococcus epidermidis plasmid expressing constitutive macrolide-lincosamide-streptogramin B resistance contains a deleted attenuttor. J Bacteriol 1986;166:479-83.
13. Rao GG. Should clindamycin be used in treatment of patients with infections caused by erythromycin-resistant staphylococci? J Antimicrob Chemother 2000;45: 715-6.
14. Siberry GK, Tekle T, Carroll K, Dick J. Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clin Infect Dis 2003;37:1257-60.
15. Schreckenberger PC, Ilendo F, Ristow KL. Incidence of constitutive and inducible clindamycin rcsistance in Staphylococcus aureus and coagulase-negative staphylococci in a community and a tertiary care hospital. J Clin Microbiol 2004;42:2777-9.
16. Almer LS, Shortridge VD, Nilius AM, Beyer JM, Soni NB, Bui MH, et al. Antimicrobial susceptibility and molecular characterization of community-acquired methicillin-resistant Staphylococcus aureus. Diagn Microbiol Infect Dis 2002;43:225-32.